Highbridge Capital Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $68M 60M 1.14
2024-06-30 $58M 45M 1.29
2023-12-31 $51B 50M 1015.44
2023-09-30 $35M 31M 1.12

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
Ford Mtr Bond (Principal)
Firstenergy Corp Bond (Principal)
Southwest Airls Bond (Principal)
Guess Bond (Principal)
Sarepta Therapeutics Bond (Principal)
Southern Bond (Principal)
Liberty Broadband Corp Common (LBRDK)
Hess Corp Common (HES)
On Semiconductor Corp Bond (Principal)
Ventas Rlty Ltd Partnership Bond (Principal)
Zillow Group Bond (Principal)
Sea Bond (Principal)
Bofa Fin Bond (Principal)
Lci Inds Bond (Principal)

View all positions for Highbridge Capital Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1